drugset / Trial / NCT03254849
Empagliflozin and Sympathetic Nerve Traffic
RandomizedParallel-groupTriple-blindTreatment
Summary
In this study the effects of the Inhibition of the Sodium-Glucose Linked Transporter 2 in the kidney with empagliflozin compared to hydrochlorothiazide on blood pressure and on central sympathic nervous activity will be examined.
Timeline
- Start
- 2017-12-08
- Primary completion
- 2020-04-20
- Completion
- 2020-04-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Empagliflozin | Small molecule | 25 mg | Oral |
| Subject | Hydrochlorothiazide | Unknown | 25 mg | Oral |